English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Community

+ Community
Amanda Rupp | Aug 31, 2016

Leaders to share Eliquis analyses at ESC Congress 2016

+ Regulatory
Amanda Rupp | Aug 31, 2016

Sandoz's Erelzi gains FDA approval for multiple inflammatory diseases

+ Technology/Innovation
Amanda Rupp | Aug 31, 2016

NIH partnership makes progress with possible Zika treatments

+ Community
Amanda Rupp | Aug 31, 2016

Autism educator answers questions about adult daughter experiencing stress

+ Community
Amanda Rupp | Aug 31, 2016

AAFP experts: family physicians can reduce unneeded breast cancer surgeries

+ Regulatory
John Breslin | Aug 31, 2016

Activists concerned by influence of Medicare advisory panel

+ Technology/Innovation
Amanda Rupp | Aug 30, 2016

#Path2Cures created to promote rare disease advocacy

+ Community
Amanda Rupp | Aug 30, 2016

Foods containing folic acid linked to reduced rate of congenital heart defects

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 435
  • 436
  • 437
  • 438
  • 439
  • 440
  • 441
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily